What amount sold does Motive Health, Inc. report in Form D filings?

The latest linked filings report $50M sold across 11 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Motive Health, Inc.'s most recent SEC filing?

Motive Health, Inc.'s most recent Form D filing was on 2026-02-18.

How many investors does Motive Health, Inc. have?

The most recent Form D filing lists 9 investor(s).

What type of securities does Motive Health, Inc. offer?

Motive Health, Inc.'s SEC Form D filings indicate debt offerings.

Motive Health, Inc.

CIK: 0001579395·Other·SCOTTSDALE, AZ·Corporation

Reported Sold

$50,034,375

Total Filings

Identified Offerings

Last Filed

Feb 18, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Feb 18, 2026Form D/A — Amendment

Reported sold: $15,047,291 · Target: $15,088,786

Rule 506(b)·9 investors

Changed: Reported amount sold, Offering target, Reported investors

Apr 2, 2025Form D/A — Amendment

Reported sold: $12,547,225 · Target: $12,562,523

Rule 506(b)·9 investors

Changed: Reported amount sold, Offering target, Reported investors

Dec 4, 2024Form D/A — Amendment

Reported sold: $9,000,000 · Target: $9,032,270

Rule 506(b)·9 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 16, 2023Form D — New notice

Reported sold: $2,934,159 · Target: $7,500,000

Rule 506(b)·1 investor

Jan 25, 2023Form D — New notice

Reported sold: $2,579,012 · Target: $6,000,000

Rule 506(b)·3 investors

Nov 22, 2021Form D — New notice

Reported sold: $3,890,992 · Target: $6,500,000

Rule 506(b)·8 investors

Apr 28, 2021Form D — New notice

Reported sold: $1,806,335 · Target: $2,500,000

Rule 506(b)·16 investors

Feb 6, 2020Form D — New notice

Reported sold: $2,112,609 · Target: $5,600,000

Rule 506(b)·2 investors

Jun 6, 2019Form D — New notice

Reported sold: $3,996,136 · Target: $6,000,000

Rule 506(b)·3 investors

Oct 1, 2018Form D — New notice

Reported sold: $3,000,000 · Target: $5,000,000

Rule 506(b)·2 investors

Jun 9, 2016Form D — New notice

Reported sold: $5,642,000 · Target: $13,000,000

Rule 506(b)·23 investors

May 19, 2015Form D — New notice

Reported sold: $5,380,000 · Target: $5,505,000

Rule 506(b)·34 investors

Jul 22, 2014Form D — New notice

Reported sold: $6,000,000 · Target: $6,000,000

Rule 506(b)·22 investors

Jun 21, 2013Form D — New notice

Reported sold: $580,000 · Target: $1,465,000

Rule 506·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

21%

Latest reported sold across 11 identified offerings

$50,034,375

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

D. Ronald Yagoda

Related Person

Appears on 14 filings

Struan H. Coleman

Related Person

Appears on 14 filings

Christopher Martin

Related Person

Appears on 13 filings

ROBERT MOROCCO

Related Person

Appears on 13 filings

Edwin F. Scheetz

Related Person

Appears on 12 filings

William Hanna

Related Person

Appears on 11 filings

Rhonda Anderson

Related Person

Appears on 10 filings

Jeffrey T. Zywicki

Related Person

Appears on 10 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 18, 2026	Amendment	$15,088,786	$15,047,291	9
Apr 2, 2025	Amendment	$12,562,523	$12,547,225	9
Dec 4, 2024	Amendment	$9,032,270	$9,000,000	9
Nov 16, 2023	New	$7,500,000	$2,934,159	1
Jan 25, 2023	New	$6,000,000	$2,579,012	3
Nov 22, 2021	New	$6,500,000	$3,890,992	8
Apr 28, 2021	New	$2,500,000	$1,806,335	16
Feb 6, 2020	New	$5,600,000	$2,112,609	2
Jun 6, 2019	New	$6,000,000	$3,996,136	3
Oct 1, 2018	New	$5,000,000	$3,000,000	2
Jun 9, 2016	New	$13,000,000	$5,642,000	23
May 19, 2015	New	$5,505,000	$5,380,000	34
Jul 22, 2014	New	$6,000,000	$6,000,000	22
Jun 21, 2013	New	$1,465,000	$580,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

ACES Diagnostics, Inc.

Other

Offering target: $8,702,366

Filed Oct 27, 2026